Have you ever wondered why some people never became sick from COVID-19? A study published today in Nature shows that common genetic variation among people is responsible for mediating SARS-CoV-2 asymptomatic infection.
Biotech IPO raising in Q1 2024 surged from Q4 2023 – but has the momentum lasted? – Pharmaceutical Technology
Biotech initial public offerings (IPOs) surged in Q1 2024, with eight completed IPOs raising a total of $3.72bn, six times more than the $621m raised